Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Abdelrahman Hamdi, Muhammad Yaseen, Wafaa A. Ewes, Mashooq Ahmad Bhat, Noha I. Ziedan, Hamed W. El-Shafey, Ahmed A. B. Mohamed, Mohamed R. Elnagar, Abdullah Haikal, Dina I. A. Othman, Abdullah A. Elgazar, Ahmed H. A. Abusabaa, Kamal S. Abdelrahman, Osama M. Soltan & Mostafa M. Elbadawi. (2023) Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Read now
Articles from other publishers (4)
Nagwa M. Abdelazeem, Wael M. Aboulthana, Ashraf S. Hassan, Abdulrahman A. Almehizia, Ahmed M. Naglah & Hamad M. Alkahtani. (2024) Synthesis, in silico ADMET prediction analysis, and pharmacological evaluation of sulfonamide derivatives tethered with pyrazole or pyridine as anti-diabetic and anti-Alzheimer's agents. Saudi Pharmaceutical Journal 32:5, pages 102025.
Crossref
Crossref
Ahmet Özdemir & Halide Edip Temel. (2024) COX inhibitory profiles of a series of thiadiazole-benzothiazole hybrids. European Journal of Life Sciences 3:1, pages 9-15.
Crossref
Crossref
Marwa I. Serag, Samar S. Tawfik, Sahar M. I. Badr & Hassan M. Eisa. (2024) New oxadiazole and pyrazoline derivatives as anti-proliferative agents targeting EGFR-TK: design, synthesis, biological evaluation and molecular docking study. Scientific Reports 14:1.
Crossref
Crossref
Sara Masoudinia, Marjaneh Samadizadeh, Maliheh Safavi, Hamid Reza Bijanzadeh & Alireza Foroumadi. (2024) Novel quinazolines bearing 1,3,4-thiadiazole-aryl urea derivative as anticancer agents: design, synthesis, molecular docking, DFT and bioactivity evaluations. BMC Chemistry 18:1.
Crossref
Crossref